Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide

Global Women’s Health Drugs Market to 2024 Research Report provides Key Marketed Products, Pipeline Landscape Assessment, Company Analysis and Positioning, Revenue and Market Share and Strategic Consolidations.

Pune, India - February 12, 2019 /MarketersMedia/ —

The women’s health therapy area covers medical disorders that affect females only, primarily disorders of the female reproductive system, including those associated with menstruation, conception, pregnancy, childbirth and menopause. Many of these disorders are highly prevalent among the female population.

The Women’s Health Market is relatively small considering the high prevalence of many women’s health indications. However, robust growth is projected over the forecast period due to the influx of a number of new products.

This report covers all indications within women’s health with a particular focus on five key indications: endometriosis, polycystic ovarian syndrome (PCOS), cervical intraepithelial neoplasia (CIN), menopausal disorders and infertility.

*Company Analysis and Positioning:
Revenue and Market Share Analysis by Company
1 Bayer AG - Company to Remain a Market Leader within Women’s Health
2 AbbVie Inc - Orilissa to Reach Blockbuster Status, Boosting Company’s Market Share
3 Allergan - Revenue Gains From Fibristal, Lo Loestrin Fe and Liletta to Offset Losses from Minastrin 24 Fe and Estrace
4 Merck & Co. - Company to Remain a Key Player Due to Growth of Gardasil/Gardasil 9
5 GlaxoSmithKline - Cervarix and Retosiban to Drive Strong Growth
6 Pfizer - How will patent expiration affect revenues for women’s health market?
7 TherapeuticsMD – Women’s Health Specialist to Gain Considerable Market Share by 2024

Get Discount on Global Women’s Health Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1854865

Scope
- There are 277 pipeline products in active development for women’s health disorders. Which molecule types and molecular targets are most prominent within the pipeline?
- Merck&Co and Bayer currently represent leading companies within women’s health. Will they maintain this dominance over the forecast period?
- Gardasil, Mirena and Nuvaring and are among the most lucrative drugs within the women’s health market. Which of these will experience a considerable decline in revenue over the forecast period following loss of patent protection?
- The influx of a number of recent market entrants and late-stage pipeline products will have a considerable impact on the women’s health market over the forecast period. Which of these drugs are projected to achieve blockbuster status by 2024?
- In total, 246 licensing deals relating to women’s health products have been completed since 2006. Which types of assets attracted the largest deal values?

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=1854865

Reasons to buy:
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyze the women’s health pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
- Consider market opportunities and potential risks by examining trends in clinical trial duration and size, as well as clinical trial failure rates.
- Predict growth in market size by examining multi-scenario forecasting trends from 2017 to 2024 and determine the contributions that different products and companies will make to this growth.
- Identify commercial opportunities in the women’s health deals landscape by analyzing trends in licensing and co-development deals.

Contact Info:
Name: Vishal Kalra
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1854865-global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide-to-diversify-landscape-and-drive-growth.html

Source URL: https://marketersmedia.com/global-womens-health-drugs-market-to-2024-influx-of-new-products-including-orilissa-relugolix-and-bremelanotide/481772

Source: MarketersMedia

Release ID: 481772

More News From The Witness Daily

The Latest: Suspect in Sacramento officer killing surrenders

Jun 20, 2019

SACRAMENTO, Calif. — The Latest on the fatal shooting of a police officer in Sacramento (all times local): 6:50 a.m. Sacramento police say a man suspected of fatally shooting a police officer who was on a domestic violence call has surrendered to authorities and is in police custody. The Sacramento Police Department said in a statement Thursday that investigators are still gathering evidence at the location where 26-year-old Officer Tara O'Sullivan was shot Wednesday. Police have said O'Sullivan was assisting a woman removing belongings from a home in the north Sacramento neighborhood when the suspect shot her. The woman was...

Unheard song from Queen frontman Freddie Mercury released

Jun 20, 2019

NEW YORK — Universal Music unveiled a previously unheard and unreleased song by the late Queen frontman Freddie Mercury. The record label announced the track, "Time Waits for No One," on Thursday. It was originally recorded in 1986 for the concept album of the musical "Time" with musician Dave Clark. A video to accompany the song was also released and includes unseen performance footage of Mercury. It was recorded in April 1986 at London's Dominion Theatre. Mercury died of AIDS-related pneumonia in 1991 at 45. He was the subject of the uber-successful film "Bohemian Rhapsody," which won actor Rami Malek...

Poll: Tracking asteroids a favored focus for space program

Jun 20, 2019

CAPE CANAVERAL, Fla. — Americans prefer a space program that focuses on potential asteroid impacts, scientific research and using robots to explore the cosmos over sending humans back to the moon or on to Mars, a new poll shows. The poll by The Associated Press and the NORC Center for Public Affairs Research, released Thursday, one month before the 50th anniversary of the Apollo 11 moon landing, lists asteroid and comet monitoring as the No. 1 desired objective for the U.S. space program. About two-thirds of Americans call that very or extremely important, and about a combined 9 in 10...

Asian shares gain, Shanghai up 2.4%, on Fed rate cut talk

Jun 20, 2019

BANGKOK — Asian shares are higher with the Shanghai benchmark up 2.4% on hopes that a meeting between President Donald Trump and his counterpart Xi Jinping next week might help ease trade tensions. The Thursday tracked modest gains on Wall Street. Tokyo's Nikkei 225 index added 0.6% to 21,462.86 while the Hang Seng in Hong Kong surged 1.2% to 28,545.23. Shanghai was up 2.4% to 2,987.12 while Australia's S&P ASX 200 picked up 0.6% to 6,687.40. India's Sensex advanced 0.4% to 39,277.17. Shares fell in Jakarta but rose slightly in Taiwan and elsewhere in Southeast Asia. Confirmation that Trump and...

AP Interview: Border official says aid needed to save lives

Jun 20, 2019

WASHINGTON — When 16-year-old Carlos Hernandez Vasquez fell ill in a holding facility at the U.S.-Mexico border, he was diagnosed with the flu and given medication, then sent back to a cell to recuperate on a concrete bench. But Carlos didn't get better. The Guatemalan migrant died May 20 from flu complications — a glaring sign that Border Patrol stations aren't set up to manage thousands of children. If they must, they need better medical care and a place for sick kids to convalesce, Acting Customs and Border Protection Commissioner John Sanders told The Associated Press. That's why Congress must...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH